Beyond the Gold Standard: Why Real-World Data Belongs in Medicine

Smart Medicine  |  06 November 2026

The patient in front of you today could help the patient someone else sees tomorrow. Dr. Amy Abernethy has spent her career making that possible, and she’s worked at nearly every stop that data passes through to figure out how.

In this episode of Smart Medicine, Dr. Scott Sigman sits down with Dr. Amy Abernethy, oncologist, former FDA Principal Deputy Commissioner, and co-founder of Highlander Health, to explore how patient data can help medicine move at the speed patients need. Together, they explore how real-world evidence is filling the gaps clinical trials leave behind, and how it’s already shaping the treatments the FDA approves. They also weigh how AI could speed up every step, as long as it comes with discipline. The conversation ends where it began, with the patient, and a practical ask for every physician listening.

Subscribe to Smart Medicine

Spread the word

Tags
Real-World Data   Real-World Evidence   FDA   Clinical Trials   AI in Healthcare   Medical Research   Oncology   Patient Outcomes   Healthcare Innovation   Smart Medicine   Dr. Abernethy   Dr. Scott Sigman  

Related insights